Thiazolidinediones and hepatic fibrosis: don't wait too long.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16766749.
- Also identified by PMC identifier 1856323.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lack of effect of delayed thiazolidinedione treatment may imply that these drugs are of limited efficacy in hepatic fibrosis, and that treatment of chronic liver disease might be successful only if the therapy were started very early
Medical subject headings
- Hypoglycemic Agents
- Liver Cirrhosis
- Thiazolidinediones